The Korean Journal of Gastroenterology (대한소화기학회지)

The Korean Society of Gastroenterology (대한소화기학회)
권호 표지

Diagnosis of Irritable Bowel Syndrome: a Systematic Review

과민성 장증후군의 진단: 체계적인 문헌고찰

Park, Jung-Ho;Byeon, Jeong-Sik;Shin, Woon-Geon;Yoon, Young-Hun;Cheon, Jae-Hee;Lee, Kwang-Jae;Park, Hyo-Jin
박정호;변정식;신운건;윤영훈;천재희;이광재;박효진;대한소화기 기능성질환.운동학회

  • Published : 20100000
⟨ Previous Next ⟩

Abstract

Irritable bowel syndrome (IBS) is a very common functional gastrointestinal disorder characterized by abdominal discomfort, bloating, and disturbed defecation. Patients with IBS have a tendency to visit physicians more frequently than those without IBS, thus annual economic consequences of IBS in the Western countries are substantial. Therefore, guidelines for the diagnosis and treatment of IBS patients have been designed to give a favored effect on the Department of Gastroenterology's overall performance. A variety of criteria have been developed to identify a combination of symptoms to diagnose IBS, including Manning and Rome I, II, and III criteria. Overall, Manning’s criteria had a pooled sensitivity and specificity, 78% and 72%, respectively. In addition, the Rome I criteria had a sensitivity and specificity, 71% and 85%, respectively. However, none described the accuracy of Rome II and III yet. Alarm features such as rectal bleeding and nocturnal pain offer little discriminative value in separating patients with IBS from those with organic diseases. Even though anemia and weight loss have poor sensitivity for organic diseases, they offer very good specificity. Since specific biomarker of IBS is not yet available, diagnostic tests are frequently performed to exclude organic diseases. However, the accuracy of diagnostic tests is disappointing. CBC, chemistry, thyroid function test, stool exam, ultrasonography, hydrogen breath test, erythrocyte sedimentation rate, and C-reactive protein have all very limited accuracy in discriminating IBS from organic diseases. This systemic review is targeted to establish the strategy of IBS treatment, which is very necessary for the current clinical practice.

Keywords

References

  1. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997;112:2120-2137 https://doi.org/10.1053/gast.1997.v112.agast972120
  2. Chey WD, Olden K, Carter E, Boyle J, Drossman D, Chang L. Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Am J Gastroenterol 2002;97:2803-2811 https://doi.org/10.1111/j.1572-0241.2002.07026.x
  3. Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990;99:409-415
  4. Han SH, Lee OY, Bae SC, et al. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. J Gastroenterol Hepatol 2006;21:1687-1692 https://doi.org/10.1111/j.1440-1746.2006.04269.x
  5. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140-1156 https://doi.org/10.1053/gast.2002.32392
  6. Azpiroz F, Dapoigny M, Pace F, et al. Nongastrointestinal disorders in the irritable bowel syndrome. Digestion 2000;62:66-72 https://doi.org/10.1159/000007780
  7. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109:1736-1741 https://doi.org/10.1016/0016-5085(95)90738-6
  8. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500-1511 https://doi.org/10.1053/gast.2002.32978
  9. Lee OY, Yoon CO. Evidence based guideline for diagnosis and treatment: diagnostic guideline for irritable bowel syndrome. Korean J Neurogastroenterol Motil 2005;11:30-35
  10. Park HJ. Evidence based guideline for diagnosis and treatment: therapeutic guideline for irritable bowel syndrome. Korean J Neurogastroenterol Motil 2005;11:36-43
  11. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2:653-654 https://doi.org/10.1136/bmj.2.6138.653
  12. Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104(suppl 1):S1-S35
  13. Dalrymple J, Bullock I. Diagnosis and management of irritable bowel syndrome in adults in primary care: summary of NICE guidance. BMJ 2008;336:556-558 https://doi.org/10.1136/bmj.39484.712616.AD
  14. Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007;56:1770-1798 https://doi.org/10.1136/gut.2007.119446
  15. Rubin G, De Wit N, Meineche-Schmidt V, Seifert B, Hall N, Hungin P. The diagnosis of IBS in primary care: consensus development using nominal group technique. Fam Pract 2006;23:687-692 https://doi.org/10.1093/fampra/cml050
  16. Frigerio G, Beretta A, Orsenigo G, Tadeo G, Imperiali G, Minoli G. Irritable bowel syndrome. Still far from a positive diagnosis. Dig Dis Sci 1992;37:164-167 https://doi.org/10.1007/BF01308166
  17. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 2004;53:666-672 https://doi.org/10.1136/gut.2003.021857
  18. Jeong H, Lee HR, Yoo BC, Park SM. Manning criteria in irritable bowel syndrome: its diagnostic significance. Korean J Intern Med 1993;8:34-39
  19. Rao KP, Gupta S, Jain AK, Agrawal AK, Gupta JP. Evaluation of Manning's criteria in the diagnosis of irritable bowel syndrome. J Assoc Physicians India 1993;41:357-358, 363
  20. Kruis W, Thieme C, Weinzierl M, Schussler P, Holl J, Paulus W. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984;87:1-7
  21. Dogan UB, Unal S. Kruis scoring system and Manning's criteria in diagnosis of irritable bowel syndrome: is it better to use combined? Acta Gastroenterol Belg 1996;59:225-228
  22. Ford AC, Talley NJ, Veldhuyzen van Zanten SJ, Vakil NB, Simel DL, Moayyedi P. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA 2008;300:1793-1805 https://doi.org/10.1001/jama.300.15.1793
  23. Banerjee R, Choung OW, Gupta R, et al. Rome I criteria are more sensitive than Rome II for diagnosis of irritable bowel syndrome in Indian patients. Indian J Gastroenterol 2005;24:164-166
  24. Hammer J, Talley NJ. Value of different diagnostic criteria for the irritable bowel syndrome among men and women. J Clin Gastroenterol 2008;42:160-166 https://doi.org/10.1097/MCG.0b013e3181574d48
  25. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002;123:450-460 https://doi.org/10.1053/gast.2002.34755
  26. Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 1999;94:2912-2917 https://doi.org/10.1111/j.1572-0241.1999.01437.x
  27. Whitehead WE, Palsson OS, Feld AD, et al. Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome. Aliment Pharmacol Ther 2006;24:137-146 https://doi.org/10.1111/j.1365-2036.2006.02956.x
  28. Mazumdar TN, Prasad KV, Bhat PV. Formulation of a scoring chart for irritable bowel syndrome (IBS): a prospective study. Indian J Gastroenterol 1988;7:101-102
  29. Bellentani S, Baldoni P, Petrella S, et al. A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group. Fam Pract 1990;7:307-312 https://doi.org/10.1093/fampra/7.4.307
  30. Jellema P, van der Windt DA, Schellevis FG, van der Horst HE. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther 2009;30:695-706 https://doi.org/10.1111/j.1365-2036.2009.04087.x
  31. Ford AC, Marwaha A, Lim A, Moayyedi P. Systematic Review and Meta-Analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia. Clin Gastroenterol Hepatol 2009;8:401-409 https://doi.org/10.1016/j.cgh.2009.07.020
  32. Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002;97(suppl 11):S7-S26
  33. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale- Update based on new evidence. Gastroenterology 2003; 124:544-560 https://doi.org/10.1053/gast.2003.50044
  34. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286-292 https://doi.org/10.1001/archinte.163.3.286
  35. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-429 https://doi.org/10.1056/NEJMra020831
  36. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002;97:2812-2819 https://doi.org/10.1111/j.1572-0241.2002.07027.x
  37. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: a casecontrol study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001;358:1504-1508 https://doi.org/10.1016/S0140-6736(01)06581-3
  38. Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994;89:176-178
  39. Hamm LR, Sorrells SC, Harding JP, et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol 1999;94:1279-1282 https://doi.org/10.1111/j.1572-0241.1999.01077.x
  40. Cash BD, Kim CH, Lee DH, et al. Yield of diagnostic testing in patients with suspected irritable bowel syndrome: a prospective, US multi-center trial. Gastroenterology 2007;132 (suppl 4): A678
  41. Francis CY, Duffy JN, Whorwell PJ, Martin DF. Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome? Am J Gastroenterol 1996;91:1348-1350
  42. Sciarretta G, Giacobazzi G, Verri A, Zanirato P, Garuti G, Malaguti P. Hydrogen breath test quantification and clinical correlation of lactose malabsorption in adult irritable bowel syndrome and ulcerative colitis. Dig Dis Sci 1984;29:1098-1104 https://doi.org/10.1007/BF01317083
  43. Farup PG, Monsbakken KW, Vandvik PO. Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study. Scand J Gastroenterol 2004;39:645-649 https://doi.org/10.1080/00365520410005405
  44. Di Stefano M, Miceli E, Mazzocchi S, Tana P, Moroni F, Corazza GR. Visceral hypersensitivity and intolerance symptoms in lactose malabsorption. Neurogastroenterol Motil 2007;19:887-895 https://doi.org/10.1111/j.1365-2982.2007.00973.x
  45. Saad RJ, Chey WD. Breath tests for gastrointestinal disease: the real deal or just a lot of hot air? Gastroenterology 2007; 133:1763-1766 https://doi.org/10.1053/j.gastro.2007.10.059
  46. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95:3503-3506 https://doi.org/10.1111/j.1572-0241.2000.03368.x
  47. Nucera G, Gabrielli M, Lupascu A, et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005;21:1391-1395 https://doi.org/10.1111/j.1365-2036.2005.02493.x
  48. Parodi A, Greco A, Savarino E, et al. May breath test be useful in diagnosis of IBS patients? An Italian study. Gastroenterology 2007;132(suppl 4):A192
  49. Paik CN, Choi MG, Nam KW, et al. The Prevalence of Small Intestinal Bacterial Overgrowth in Korean Patients with Irritable Bowel Syndrome. Korean J Gastrointest Motil 2007;13:38-44
  50. Lupascu A, Gabrielli M, Lauritano EC, et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005;22:1157-1160 https://doi.org/10.1111/j.1365-2036.2005.02690.x
  51. McCallum R, Schultz C, Sostarich S. Evaluating the role of small intestinal bacterial overgrowth in diarrhea predominant irritable bowel syndrome patients utilizing the glucose breath test. Gastroenterology 2005;128(suppl 2):A460
  52. Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007;56:802-808 https://doi.org/10.1136/gut.2006.108712
  53. Roka R, Rosztoczy A, Leveque M, et al. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea- predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007;5:550-555 https://doi.org/10.1016/j.cgh.2006.12.004
  54. Ameen VZ, Patterson MH, Colopy MW, et al. Confirmation of presumptive diagnosis of irritable bowel syndrome utilizing Rome II criteria and simple laboratory screening tests with diagnostic GI evaluation. Gastroenterology 2001;120(suppl1):A635
  55. Nojkov B, Rubenstein JH, Cash BD, et al. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome (IBS): results from a prospective, controlled US trial. Gastroenterology 2008;134(suppl 1):A30